Moneycontrol Be a Pro
Get App
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Profit & Loss account - Glenmark Pharma

Glenmark Pharma

BSE: 532296|NSE: GLENMARK|ISIN: INE935A01035|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Dec 13, 16:00
339.70
-1.65 (-0.48%)
VOLUME 72,257
LIVE
NSE
Dec 13, 15:58
339.60
-2 (-0.59%)
VOLUME 1,211,329
Download Annual Report PDF Format 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010

Profit & Loss account of Glenmark Pharma

------------------- in Rs. Cr. -------------------
Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
12 mths 12 mths 12 mths 12 mths 12 mths
INCOME
Revenue From Operations [Gross] 6,131.14 6,096.05 7,694.83 5,906.97 5,199.63
Less: Excise/Sevice Tax/Other Levies 0.00 0.00 0.00 87.91 200.42
Revenue From Operations [Net] 6,131.14 6,096.05 7,694.83 5,819.06 4,999.21
Other Operating Revenues 173.73 335.83 400.67 296.11 86.39
Total Operating Revenues 6,304.87 6,431.88 8,095.50 6,115.17 5,085.60
Other Income 475.61 180.42 148.24 117.28 84.94
Total Revenue 6,780.48 6,612.31 8,243.74 6,232.45 5,170.54
EXPENSES
Cost Of Materials Consumed 1,585.85 2,038.57 2,242.01 1,792.24 1,564.03
Purchase Of Stock-In Trade 301.30 288.18 267.00 219.98 173.95
Changes In Inventories Of FG,WIP And Stock-In Trade 471.81 51.85 -83.52 -73.55 -69.65
Employee Benefit Expenses 969.98 1,021.92 914.47 766.25 662.25
Finance Costs 223.81 190.90 152.60 36.22 30.19
Depreciation And Amortisation Expenses 106.28 118.20 104.93 99.81 119.46
Other Expenses 1,648.45 1,683.87 1,856.90 1,644.97 1,290.03
Total Expenses 5,307.48 5,393.48 5,454.39 4,485.92 3,770.26
Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
12 mths 12 mths 12 mths 12 mths 12 mths
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax 1,473.00 1,218.83 2,789.35 1,746.53 1,400.28
Exceptional Items 345.19 0.00 -236.45 0.00 -168.74
Profit/Loss Before Tax 1,818.18 1,218.83 2,552.90 1,746.53 1,231.55
Tax Expenses-Continued Operations
Current Tax 383.50 270.68 604.02 374.62 280.17
Less: MAT Credit Entitlement 0.00 0.00 0.00 0.00 52.69
Deferred Tax -53.61 -66.20 -191.74 -112.35 -3.46
Total Tax Expenses 329.88 204.48 412.29 262.26 224.02
Profit/Loss After Tax And Before ExtraOrdinary Items 1,488.30 1,014.35 2,140.61 1,484.27 1,007.53
Profit/Loss From Continuing Operations 1,488.30 1,014.35 2,140.61 1,484.27 1,007.53
Profit Loss From Discontinuing Operations 202.83 0.00 0.00 0.00 0.00
Total Tax Expenses Discontinuing Operations 69.03 0.00 0.00 0.00 0.00
Net Profit Loss From Discontinuing Operations 133.81 0.00 0.00 0.00 0.00
Profit/Loss For The Period 1,622.11 1,014.35 2,140.61 1,484.27 1,007.53
Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
12 mths 12 mths 12 mths 12 mths 12 mths
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.) 57.49 35.95 75.86 52.87 37.14
Diluted EPS (Rs.) 57.49 35.94 75.84 52.86 37.13
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS
Imported Raw Materials 0.00 0.00 0.00 386.60 359.92
Indigenous Raw Materials 0.00 0.00 0.00 1,347.96 1,149.08
STORES, SPARES AND LOOSE TOOLS
Indigenous Stores And Spares 0.00 0.00 0.00 56.01 55.02
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend 68.03 67.92 67.95 67.92 54.26
Tax On Dividend 0.00 0.00 0.00 0.00 11.35
Equity Dividend Rate (%) 200.00 200.00 200.00 200.00 200.00
Source : Dion Global Solutions Limited

Results of Pharmaceuticals Sector

  • News
  • Results
  • Estimates
  • Analysis
No news.
Quick Links for glenmarkpharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.